CHEVY CHASE, Maryland, June 6 – Scientists from the Human Genome Project and Celera Genomics left their long-standing rivalry behind Wednesday to participate in the Joint Genome Sequencing Workshop, a meeting designed to seek consensus on the best approach to genome sequencing. 

“The goal is to try to look forward and understand what common ground we have, and how to best move forward into the future,” said Gene Myers, Celera’s vice president for informatics research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.